Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Graft-versus-host disease | R-HSA-1643685 | map05332 | doxorubicin | 4044 | drug-path |
| Natural killer cell mediated cytotoxicity | R-HSA-5218921 | map04650 | doxorubicin | 4044 | drug-path |
| Hematopoietic cell lineage | R-HSA-173752 | map04640 | doxorubicin | 4044 | drug-path |
| PPAR signaling pathway | R-HSA-168638 | map03320 | doxorubicin | 4044 | drug-path |
| Alzheimer's disease | R-HSA-1643685 | 0 | doxorubicin | 4044 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | doxorubicin | 4044 | drug-path |
| Taste transduction | R-HSA-162582 | map04742 | doxorubicin | 4044 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | doxorubicin | 4044 | drug-path |
| Antigen processing and presentation | R-HSA-1236975 | map04612 | doxorubicin | 4044 | drug-path |
| Leukocyte transendothelial migration | R-HSA-8950732 | map04670 | doxorubicin | 4044 | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | doxorubicin | 4044 | drug-path |
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | doxorubicin | 4044 | drug-path |
| Focal adhesion | R-HSA-354113 | map04510 | doxorubicin | 4044 | drug-path |
| Primary immunodeficiency | R-HSA-5601905 | map05340 | doxorubicin | 4044 | drug-path |
| Tight junction | R-HSA-2134514 | map04530 | doxorubicin | 4044 | drug-path |
| Long-term potentiation | R-HSA-9620244 | map04720 | doxorubicin | 4044 | drug-path |
| Vibrio cholerae infection | R-HSA-9609646 | map05110 | doxorubicin | 4044 | drug-path |
| Asthma | R-HSA-444620 | map05310 | doxorubicin | 4044 | drug-path |
| ECM-receptor interaction | R-HSA-373711 | map04512 | doxorubicin | 4044 | drug-path |
| Chemokine signaling pathway | R-HSA-168638 | map04062 | doxorubicin | 4044 | drug-path |